Literature DB >> 10571609

Helicobacter pylori infection is a protective factor for bleeding gastric ulcers but not for bleeding duodenal ulcers in NSAID users.

S Santolaria1, A Lanas, R Benito, M f Pérez-Aisa, M Montoro, R Sainz.   

Abstract

BACKGROUND: The effect of Helicobacter pylori infection on NSAID-induced gastroduodenal damage is unclear. AIM: To determine the role of H. pylori and NSAID use in complicated peptic ulcers.
METHODS: A total of 185 consecutive patients with bleeding peptic ulcers and 185 hospitalized matched controls were studied prospectively. Additionally, 75 consecutive uncomplicated peptic ulcers and 75 community controls were also studied. Active H. pylori infection was determined by urea breath test and/or both urease test and histology. Serum CagA and VacA status were determined at random in 135 infected patients and 82 controls. NSAID use was determined by structured data collection.
RESULTS: H. pylori (odds ratio [OR]=5. 98; 2.9-12.3) and NSAID use (OR=5.74; 3.4-9.7) were independent risk factors for duodenal ulcer bleeding, whereas NSAID use was the main risk factor for bleeding gastric ulcers (OR=12.4; 5.5-27.9). Interaction of both factors was associated with reduced risk for bleeding gastric ulcers (OR=0.19; 0.04-0.88) but not for bleeding duodenal ulcers, which showed a similar risk to any one factor alone. This was observed for all types of NSAID use, including low-dose aspirin, and infection by CagA positive strains. H. pylori was the only factor involved in common uncomplicated duodenal ulcers.
CONCLUSION: Interaction of both H. pylori infection and NSAID use decreases the risk of bleeding due to gastric ulcers, but not that due to duodenal ulcers.

Entities:  

Mesh:

Year:  1999        PMID: 10571609     DOI: 10.1046/j.1365-2036.1999.00631.x

Source DB:  PubMed          Journal:  Aliment Pharmacol Ther        ISSN: 0269-2813            Impact factor:   8.171


  14 in total

1.  Non-invasive testing for Helicobacter pylori in patients hospitalized with peptic ulcer hemorrhage: a cost-effectiveness analysis.

Authors:  Ashish Atreja; Alex Z Fu; Madhusudan R Sanaka; John J Vargo
Journal:  Dig Dis Sci       Date:  2009-07-07       Impact factor: 3.199

2.  Low-dose acetylsalicylic acid use and the risk of upper gastrointestinal bleeding: a meta-analysis of randomized clinical trials and observational studies.

Authors:  Vera E Valkhoff; Miriam C J M Sturkenboom; Catherine Hill; Sander Veldhuyzen van Zanten; Ernst J Kuipers
Journal:  Can J Gastroenterol       Date:  2013-03       Impact factor: 3.522

Review 3.  Interaction or relationship between Helicobacter pylori and non-steroidal anti-inflammatory drugs in upper gastrointestinal diseases.

Authors:  Kai-Yu Ji; Fu-Lian Hu
Journal:  World J Gastroenterol       Date:  2006-06-28       Impact factor: 5.742

4.  The influence of etiologic factors on clinical outcome in patients with peptic ulcer bleeding.

Authors:  Neven Ljubičić; Zeljko Puljiz; Ivan Budimir; Alen Bišćanin; Andre Bratanić; Tajana Pavić; Marko Nikolić; Davor Hrabar; Vladimir Supanc
Journal:  Dig Dis Sci       Date:  2012-06-27       Impact factor: 3.199

Review 5.  Role of Helicobacter pylori eradication in aspirin or non-steroidal anti-inflammatory drug users.

Authors:  George-V Papatheodoridis; Athanasios-J Archimandritis
Journal:  World J Gastroenterol       Date:  2005-07-07       Impact factor: 5.742

6.  Case-control study on the association of upper gastrointestinal bleeding and nonsteroidal anti-inflammatory drugs in Japan.

Authors:  Choitsu Sakamoto; Kentaro Sugano; Shinichi Ota; Nobuhiro Sakaki; Shin'ichi Takahashi; Yukio Yoshida; Taku Tsukui; Hiroyuki Osawa; Yukihiro Sakurai; Junji Yoshino; Yuji Mizokami; Tetsuya Mine; Tetsuo Arakawa; Hajime Kuwayama; Katsunori Saigenji; Koji Yakabi; Tsutomu Chiba; Tooru Shimosegawa; Jane E Sheehan; Susana Perez-Gutthann; Takuhiro Yamaguchi; David W Kaufman; Tsugumichi Sato; Kiyoshi Kubota; Akira Terano
Journal:  Eur J Clin Pharmacol       Date:  2006-07-04       Impact factor: 2.953

7.  Gastric acid secretion level modulates the association between Helicobacter pylori infection and low-dose aspirin-induced gastropathy.

Authors:  Katsunori Iijima; Nobuyuki Ara; Yasuhiko Abe; Tomoyuki Koike; Wataru Iwai; Kaname Uno; Naoki Asano; Akira Imatani; Shuichi Ohara; Tooru Shimosegawa
Journal:  J Gastroenterol       Date:  2011-02-26       Impact factor: 7.527

Review 8.  Cyclooxygenase 2-implications on maintenance of gastric mucosal integrity and ulcer healing: controversial issues and perspectives.

Authors:  F Halter; A S Tarnawski; A Schmassmann; B M Peskar
Journal:  Gut       Date:  2001-09       Impact factor: 23.059

9.  The association of Helicobacter pylori infection and nonsteroidal anti-inflammatory drugs in peptic ulcer disease.

Authors:  Juan Carlos Zapata-Colindres; Sergio Zepeda-Gómez; Aldo Montaño-Loza; Edgar Vázquez-Ballesteros; José de Jesús Villalobos; Francisco Valdovinos-Andraca
Journal:  Can J Gastroenterol       Date:  2006-04       Impact factor: 3.522

10.  Association of interleukin 1 gene family polymorphisms with duodenal ulcer disease.

Authors:  M A García-González; A Lanas; P H M Savelkoul; S Santolaria; R Benito; J B A Crusius; A S Peña
Journal:  Clin Exp Immunol       Date:  2003-12       Impact factor: 4.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.